This story describes the progress made in researching and developing genetically targeted cancer drugs and how their use has dramatically altered the landscape of cancer therapy, enabling patients with previously intractable conditions such as lung cancer,melanoma, and advanced breast cancer to live several years longer than expected and often allowing stage 4 patients to live full lives.
